Literature DB >> 30256441

Mitochondrial dynamic alterations regulate melanoma cell progression.

Fulya Dal Yontem1,2, Sun-Hee Kim2, Zhen Ding2, Elizabeth Grimm2, Suhendan Ekmekcioglu2, Handan Akcakaya1.   

Abstract

Research on mitochondrial fusion and fission (mitochondrial dynamics) has gained much attention in recent years, as it is important for understanding many biological processes, including the maintenance of mitochondrial functions, apoptosis, and cancer. The rate of mitochondrial biosynthesis and degradation can affect various aspects of tumor progression. However, the role of mitochondrial dynamics in melanoma progression remains controversial and requires a mechanistic understanding to target the altered metabolism of cancer cells. Therefore, in our study, we disrupted mitochondrial fission with mdivi-1, the reported inhibitor of dynamin related protein 1 (Drp1), and knocked down Drp1 and Mfn2 to evaluate the effects of mitochondrial dynamic alterations on melanoma cell progression. Our confocal study results showed that mitochondrial fission was inhibited both in mdivi-1 and in Drp1 knockdown cells and, in parallel, mitochondrial fusion was induced. We also found that mitochondrial fission inhibition by mdivi-1 induced cell death in melanoma cells. However, silencing Drp1 and Mfn2 did not affect cell viability, but enhanced melanoma cell migration. We further show that dysregulated mitochondrial fusion by Mfn2 knockdowns suppressed the oxygen consumption rate of melanoma cells. Together, our findings suggest that mitochondrial dynamic alterations regulate melanoma cell migration and progression.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  fission; fusion; melanoma; migration; mitochondrial dynamics

Year:  2018        PMID: 30256441     DOI: 10.1002/jcb.27518

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer.

Authors:  Danchen Wu; Asish Dasgupta; Austin D Read; Rachel E T Bentley; Mehras Motamed; Kuang-Hueih Chen; Ruaa Al-Qazazi; Jeffrey D Mewburn; Kimberly J Dunham-Snary; Elahe Alizadeh; Lian Tian; Stephen L Archer
Journal:  Free Radic Biol Med       Date:  2021-01-12       Impact factor: 8.101

Review 2.  Targeting Cancer with Phytochemicals via Their Fine Tuning of the Cell Survival Signaling Pathways.

Authors:  Salvatore Chirumbolo; Geir Bjørklund; Roman Lysiuk; Antonio Vella; Larysa Lenchyk; Taras Upyr
Journal:  Int J Mol Sci       Date:  2018-11-12       Impact factor: 5.923

3.  Protease Inhibitor Anti-HIV, Lopinavir, Impairs Placental Endocrine Function.

Authors:  Camille Fraichard; Fidéline Bonnet-Serrano; Christelle Laguillier-Morizot; Marylise Hebert-Schuster; René Lai-Kuen; Jeanne Sibiude; Thierry Fournier; Marie Cohen; Jean Guibourdenche
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

Review 4.  Mitochondrial Metabolism in Melanoma.

Authors:  Christina Huang; Rakan H Radi; Jack L Arbiser
Journal:  Cells       Date:  2021-11-16       Impact factor: 6.600

5.  2D Analysis of Gold Weight Implantation Surgery Results in Paralytic Lagophthalmos.

Authors:  Kubra Serefoğlu Cabuk; Gamze Ozturk Karabulut; Korhan Fazil; Senay Asik Nacaroglu; Zehra Karaagac Gunaydin; Muhittin Taskapili
Journal:  Beyoglu Eye J       Date:  2021-09-27

6.  Acid Sphingomyelinase Downregulation Enhances Mitochondrial Fusion and Promotes Oxidative Metabolism in a Mouse Model of Melanoma.

Authors:  Marco Coazzoli; Alessandra Napoli; Paulina Roux-Biejat; Clara De Palma; Claudia Moscheni; Elisabetta Catalani; Silvia Zecchini; Vincenzo Conte; Matteo Giovarelli; Sonia Caccia; Patrizia Procacci; Davide Cervia; Emilio Clementi; Cristiana Perrotta
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.